Back
Sep 30
Scientific
SS 33 - GI 2: Giving Radiation a Boost in Pancreatic Cancer and Responding to the Call for Esophageal Cancer
MODERATOR(S)
Eric Miller, MD, PhD - Ohio State University
Jamie Takayesu, MD - University of Washington
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
08:00am - 09:00am PT
GI 2: Giving radiation a boost in pancreatic cancer and responding to the call for esophageal cancer
Speaker: Jamie Takayesu, MD - University of Washington, Seattle -
08:00am - 08:10am PT
Sequential Chemo-Immunotherapy as a Novel Bridging Strategy for Non-Complete Responders after Neoadjuvant Chemoradiotherapy in Esophageal Cancer: First Prospective Phase 2 Trial Challenging Immediate Surgery Paradigm
Speaker: Qifeng Wang, MD - Sichuan Cancer Hospital and Institute, Chengdu -
08:00am - 09:00am PT
GI 2: Giving radiation a boost in pancreatic cancer and responding to the call for esophageal cancer
Speaker: Eric Miller, MD, PhD - Ohio State University, Columbus -
08:10am - 08:20am PT
Definitive Stereotactic Body Radiation Therapy for Resectable Non-Metastatic Pancreatic Ductal Adenocarcinoma: A Multi-Center Retrospective Analysis
Speaker: Michael Chuong, MD - Miami Cancer Institute at Baptist Health South Florida, Miami -
08:20am - 08:30am PT
-
08:30am - 08:40am PT
-
08:40am - 08:50am PT
Patient-Specific TP53-Mutant Circulating Tumor DNA as a Prognostic Biomarker for Detection of Minimal Residual Disease after Neoadjuvant Concurrent Chemoradiotherapy followed by Esophagectomy in Locally Advanced Esophageal Squamous Cell Carcinoma
Speaker: Jason Chia-Hsien Cheng, MD, PhD, MS, FASTRO - National Taiwan University Hospital, Taipei -
08:50am - 09:00am PT
Discussant
Speaker: Ethan Ludmir, MD - The University of Texas MD Anderson Cancer Center, Houston